Omega-6 fatty acids are essential polyunsaturated fatty acids, which are not produced by the human body and hence must be obtained from the diet. They are unsaturated fatty acids and are a special type of “good fat”. They are crucial for the development, functioning, and maintenance of brain and other nervous tissues, bone health, metabolism, growth of skin and hair, and reproductive system health. Omega-6 fatty acids are essentially found in vegetable oils such as safflower, corn, soybean, and sunflower. 

According to the World Health Organization, there is an increase in the burden of chronic diseases such as cardiovascular diseases, obesity, and diabetes worldwide. In 2001, chronic diseases contributed approximately 46% of the global burden of disease and is expected to increase to 57% by 2020. With this increase in rates of diseases, the use of omega-6 fatty acids in pharmaceutical products has witnessed multifold growth, thereby boosting the market for omega-6 fatty acids. Furthermore, these healthy acids promote remarkable skin benefits such as building blocks of healthy cell membranes and keeps skin hydrated. In addition, there is a rise in the demand for use of natural ingredients in manufacturing cosmetics. This ultimately has a positive impact on the market for omega-6 fatty acids. However, new players are facing tuff competition from the existing established international players as they struggle with quality issues, reliability, and technological innovations. 

On the contrary, rise in demand in the emerging countries for dietary supplements which contain the essential fatty acids and their increase in application through R&D are expected to remain opportunistic for the manufacturers to expand the market base. 

The market is segmented based on source, application and region. Based on source, it is classified into nuts, cereals, vegetable oils, whole grains, and others. Based on application, it is divided into dietary supplements, pharmaceuticals and functional foods and beverages. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA. 
The key players in the market include DSM, Omega Protein, FMC Corporation, Cargill, Incorporated, The Dow Chemical Company, Omegavia, BASF, Koninklijke DSM NV, Enzymotec Ltd., and Croda International PLC.

KEY BENEFITS FOR STAKEHOLDERS

• The report provides an in-depth analysis of the current trends, drivers, and dynamics of the omega 6 fatty acids market to elucidate the prevailing opportunities and tap the investment pockets.
• It offers qualitative trends as well as quantitative analysis of the global market from 2018 to 2025 to assist stakeholders to understand the market scenario.
• In-depth analysis of the key segments demonstrates the sources of omega-6 fatty acids and its applications.  
• Competitive intelligence of the industry highlights the business practices followed by key players across geographies as well as the prevailing market opportunities.
• Key market players are profiled to understand the competitive outlook of the market.

KEY MARKET SEGMENTS 

By Source

• Nuts
• Cereals
• Vegetable Oils
• Whole Grains
• Others

By Application

• Dietary Supplements
• Pharmaceuticals
• Functional Foods & Beverages

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Spain
  • Rest of Europe
• Asia-Pacific
  • India
  • China
  • Australia
  • Japan
  • Rest of Asia-Pacific
• LAMEA
  • Turkey
  • Brazil
  • Saudi Arabia
  • South Africa

KEY MARKET PLAYERS INCLUDE

• DSM
• Omega Protein
• FMC Corporation
• Cargill Incorporated
• The Dow Chemical Company
• Omegavia
• BASF
• Koninklijke DSM NV
• Enzymotec Ltd.
• Croda International PLC.